Cowan, Brandon
Chan, Priscilla H.
Patel, Sahil S.
Prentice, Heather A.
Sucher, Kenneth
Paxton, Elizabeth W.
Brill, Elliott R.
Malhotra, Lavina
Maertens, Francisca M.
Heitmann, Gregory M.
Mostaedi, Rouzbeh
Article History
Received: 21 January 2025
Accepted: 13 July 2025
First Online: 26 August 2025
Declarations
:
: This study was presented, #4432, at the ACS 2024 Clinical Congress in San Francisco, CA. No external funding was received for any aspect of this work.
: Brandon Cowan has a financial interest with Johnson & Johnson, unrelated to this work. The authors report no further financial interests. The authors report no non-financial interests. Each author certifies that his or her institution approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research. This work was performed at Medical Device Surveillance & Assessment, Southern California Permanente Medical Group, San Diego, CA, USA. This study was approved by the Kaiser Permanente Institutional Review Board IRB #12843.